QGEN · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $7.1B · 5,654 employees
262
SEC Filings
$44.79
Close 2026-10-07
5,654
Employees
Business Summary
QIAGEN N.V. is a life sciences company that provides sample and assay technologies used in molecular diagnostics, applied testing, pharma, and academic research. The company offers products and services across its strategy, business model, and value chain, including conflict minerals compliance, and operates under various government regulations. Specific product details are referenced in supplementary sections of the filing.
Look up QGEN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on QGEN, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/QGEN (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.